Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07339384
What this trial is testing

Signatera Assessment in Early-Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
Natera, Inc. 1,010
Not applicableUnknownNCT05595798
What this trial is testing

EEG Spectral Pattern of Deep Sedation-induced Airway Adverse Effects

Who this might be right for
Procedural Sedation
National Taiwan University Hospital 60
Not applicableUnknownNCT03577951
What this trial is testing

Comparing the Establishment of Operation Space Between High Position and Low Position in Endoscopic Thyroid Surgery

Who this might be right for
Thyroid CancerEndoscopy
Fujian Medical University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05498272
What this trial is testing

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Who this might be right for
Prostate CancerBRCA1 MutationBRCA2 Mutation+2 more
Rana McKay, MD 32
Not applicableStudy completedNCT03045445
What this trial is testing

"Double Low-Dose" DECT for HCC Imaging

Who this might be right for
HCC
Seoul National University Hospital 68
Testing effectiveness (Phase 2)Study completedNCT00003039
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40
Post-approval studies (Phase 4)Ended earlyNCT00200629
What this trial is testing

Both Exercise and Adenosine Stress Testing

Who this might be right for
Coronary Artery Disease
Midwest Heart Foundation 200
Testing effectiveness (Phase 2)Study completedNCT00842114
What this trial is testing

Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Fundación Leucemia y Linfoma, Spain 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04246684
What this trial is testing

Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients

Who this might be right for
Rectal Cancer Stage III
Prof. Dr. med. Claus Rödel 702
Early research (Phase 1)Study completedNCT00651144
What this trial is testing

Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 40
Not applicableStudy completedNCT01488032
What this trial is testing

Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma

Who this might be right for
Normal Tension GlaucomaHigh Tension Glaucoma
Technische Universität Dresden 44
Large-scale testing (Phase 3)Ended earlyNCT04266301
What this trial is testing

Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Novartis Pharmaceuticals 530
Not applicableLooking for participantsNCT07778212
What this trial is testing

Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaIntermediate-High RiskFirst-Line
The First Affiliated Hospital of Xiamen University 30
Post-approval studies (Phase 4)UnknownNCT00415792
What this trial is testing

Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs

Who this might be right for
Infertility
Eugonia 60
Testing effectiveness (Phase 2)Study completedNCT00006125
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology
Not applicableStudy completedNCT01542021
What this trial is testing

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate CancerProstatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 41
Large-scale testing (Phase 3)UnknownNCT03280979
What this trial is testing

Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia

Who this might be right for
Gestational Trophoblastic Disease
Assiut University 170
Not applicableStudy completedNCT04699162
What this trial is testing

Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Christian Omar Ramos-Peñafiel, MD, PhD 56
Not applicableStudy completedNCT01644084
What this trial is testing

A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients

Who this might be right for
Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Yonsei University 54
Not applicableUnknownNCT05919758
What this trial is testing

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

Who this might be right for
NeoplasmsAppendix Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,000
Next Page